Bryn Mawr Capital Management’s Labcorp LH Stock Holding History

Bryn Mawr Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$606K	Buy	2,272 +580	+34%	+$157K	0.03%	259
2025 Q4	$425K	Sell	1,692 -380	-18%	-$101K	0.02%	297
2025 Q3	$595K	Buy	2,072 +5	+0.2%	+$1.34K	0.03%	250
2025 Q2	$543K	Buy	2,067 +12	+0.6%	+$2.92K	0.03%	259
2025 Q1	$478K	Sell	2,055 -15	-0.7%	-$3.64K	0.03%	260
2024 Q4	$475K	Buy	2,070 +1,081	+109%	+$248K	0.03%	285
2024 Q3	$221K	Buy	+989	New	+$217K	0.01%	380
2024 Q2	–	Sell	-966	Closed	-$211K	–	402
2024 Q1	$211K	Hold	966	–	–	0.01%	382
2023 Q4	$220K	Buy	966 +323	+50%	+$67.9K	0.01%	375
2023 Q3	$129K	Buy	+643	New	+$136K	0.01%	383

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bryn Mawr Capital Management's LH Position: Q1 2026 in Review

Bryn Mawr Capital Management increased its Labcorp (LH) stake by 34% in Q1 2026, buying an estimated $157K and bringing the position to 2,272 shares worth $606K. The position accounts for 0.03% of the portfolio, ranked #259.

Bryn Mawr Capital Management first reported a position in LH in Q3 2023 and has held it in 10 quarters since. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Bryn Mawr Capital Management held 2,272 shares of Labcorp worth $606K as of Q1 2026.
Bryn Mawr Capital Management bought 580 Labcorp shares in Q1 2026, an estimated $157K.
Labcorp made up 0.03% of Bryn Mawr Capital Management's portfolio in Q1 2026, its #259 holding.
Bryn Mawr Capital Management first reported a position in Labcorp in Q3 2023 and has held it in 10 quarters since.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Bryn Mawr Capital Management's 13F filing for Q1 2026, filed 4 May 2026.